Utilize este identificador para referenciar este registo: http://hdl.handle.net/10362/66258
Título: Clinical-grade oncolytic adenovirus purification using polysorbate 20 as an alternative for cell lysis
Autor: Moleirinho, Mafalda G.
Rosa, Sara
Carrondo, Manuel J.T.
Silva, Ricardo J. S.
Hagner-McWhirter, Åsa
Ahlén, Gustaf
Lundgren, Mats
Alves, Paula M.
Peixoto, Cristina
Palavras-chave: Adenovirus
Cell lysis
Downstream processing
GMP process development
Oncolytic virus
Polysorbate 20
Molecular Medicine
Molecular Biology
Genetics
Drug Discovery
Genetics(clinical)
SDG 3 - Good Health and Well-being
Data: 1-Jan-2018
Resumo: Introduction: Oncolytic virus therapy is currently considered as a promising therapeutic approach for cancer treatment. Adenovirus is well-known and extensively characterized as an oncolytic agent. The increasing number of clinical trials using this virus generates the demand for the development of a well-established purification approach. Triton X-100 is commonly used in cell lysis buffer preparations. The addition of this surfactant in the list of substances with the very high concern of the Registration, Evaluation, Authorization and Restriction of Chemicals (REACH) regulation promoted the research for effective alternatives. Methods: In this work, a purification strategy for oncolytic adenovirus compatible with phase I clinical trials, using an approved surfactant – Polysorbate 20 was developed. The proposed downstream train, composed by clarification, concentration using tangential flow filtration, intermediate purification with anion exchange chromatography, followed by a second concentration and a final polishing step was evaluated for both Triton X-100 and Polysorbate 20 processes. The impact of cell lysis with Polysorbate20 and Triton X-100 for each downstream step was evaluated in terms of product recovery and impurities removal. Overall, 61 ± 4% of infectious viral particles were recovered. Depletion of host cell proteins and ds-DNA was 99.9% and 97.1%, respectively. Results & Conclusion: The results indicated that Polysorbate 20 can be used as a replacement for Triton X-100 during cell lysis with no impact on product recovery, potency, and purity. Moreover, the developed process is scalable and able to provide a highly purified product to be used in phase I and II clinical trials.
Descrição: PD/BD/114034/2015
Peer review: yes
URI: http://www.scopus.com/inward/record.url?scp=85058877688&partnerID=8YFLogxK
DOI: https://doi.org/10.2174/1566523218666181109141257
ISSN: 1566-5232
Aparece nas colecções:Home collection (FCT)

Ficheiros deste registo:
Ficheiro Descrição TamanhoFormato 
CGT_18_366.pdf4,48 MBAdobe PDFVer/Abrir


FacebookTwitterDeliciousLinkedInDiggGoogle BookmarksMySpace
Formato BibTex MendeleyEndnote 

Todos os registos no repositório estão protegidos por leis de copyright, com todos os direitos reservados.